{"id":403406,"date":"2024-10-20T05:05:58","date_gmt":"2024-10-20T05:05:58","guid":{"rendered":"https:\/\/pdfstandards.shop\/product\/uncategorized\/bs-en-iso-10993-72008a12022-tc\/"},"modified":"2024-10-26T09:05:32","modified_gmt":"2024-10-26T09:05:32","slug":"bs-en-iso-10993-72008a12022-tc","status":"publish","type":"product","link":"https:\/\/pdfstandards.shop\/product\/publishers\/bsi\/bs-en-iso-10993-72008a12022-tc\/","title":{"rendered":"BS EN ISO 10993-7:2008+A1:2022 – TC"},"content":{"rendered":"
PDF Pages<\/th>\n | PDF Title<\/th>\n<\/tr>\n | ||||||
---|---|---|---|---|---|---|---|
1<\/td>\n | 30455191 <\/td>\n<\/tr>\n | ||||||
149<\/td>\n | A-30355037 <\/td>\n<\/tr>\n | ||||||
150<\/td>\n | National foreword <\/td>\n<\/tr>\n | ||||||
154<\/td>\n | European foreword <\/td>\n<\/tr>\n | ||||||
155<\/td>\n | Annex ZA (informative) Relationship between this International Standard and the Essential Requirements of EU Directive 93\/42\/EEC Medical devices <\/td>\n<\/tr>\n | ||||||
156<\/td>\n | Annex ZB (informative) Relationship between this International Standard and the Essential Requirements of EU Directive 90\/385\/EEC on Active Implantable Medical Devices <\/td>\n<\/tr>\n | ||||||
158<\/td>\n | Foreword <\/td>\n<\/tr>\n | ||||||
159<\/td>\n | 1 Scope 2 Normative references 3 Terms and definitions <\/td>\n<\/tr>\n | ||||||
160<\/td>\n | 4 Requirements 4.1 General 4.2 Categorization of devices <\/td>\n<\/tr>\n | ||||||
161<\/td>\n | 4.3 Allowable limits 4.3.1 General 4.3.2 Permanent contact devices 4.3.3 Prolonged exposure devices <\/td>\n<\/tr>\n | ||||||
162<\/td>\n | 4.3.4 Limited exposure devices 4.3.5 Tolerable contact limits for surface contacting devices and implants 4.3.6 Special situations <\/td>\n<\/tr>\n | ||||||
163<\/td>\n | 4.4 Determination of EO and ECH residuals 4.4.1 General 4.4.2 Determination of residue <\/td>\n<\/tr>\n | ||||||
164<\/td>\n | 4.4.3 Product sampling and sample \u201cblank\u201d <\/td>\n<\/tr>\n | ||||||
165<\/td>\n | 4.4.4 Sample\/fluid ratios 4.4.5 Extraction time and conditions 4.4.6 Product extraction <\/td>\n<\/tr>\n | ||||||
167<\/td>\n | 4.4.7 Data analysis and interpretation <\/td>\n<\/tr>\n | ||||||
168<\/td>\n | 5 Product release 5.1 General 5.2 Release of products without dissipation curve data 5.3 Procedure for product release using residue dissipation curves <\/td>\n<\/tr>\n | ||||||
170<\/td>\n | Bibliography <\/td>\n<\/tr>\n | ||||||
182<\/td>\n | Annex A (normative) Evaluation of gas chromatograms <\/td>\n<\/tr>\n | ||||||
185<\/td>\n | Annex B (informative) Gas chromatographic determination for EO and ECH <\/td>\n<\/tr>\n | ||||||
189<\/td>\n | Annex C (informative) Flowchart and guidance for the application of this part of ISO 10993 series of standards to the determination of EO and ECH residuals in medical devices <\/td>\n<\/tr>\n | ||||||
196<\/td>\n | Annex D (informative) Factors influencing product residual <\/td>\n<\/tr>\n | ||||||
198<\/td>\n | Annex E (informative) Extraction conditions for determination of residual EO <\/td>\n<\/tr>\n | ||||||
199<\/td>\n | Annex F (informative) Rationale for the provisions of this part of ISO 10993 <\/td>\n<\/tr>\n | ||||||
203<\/td>\n | Annex G (informative) Establishment of allowable limits for EO <\/td>\n<\/tr>\n | ||||||
220<\/td>\n | Annex H (informative) Establishment of allowable limits for ECH <\/td>\n<\/tr>\n | ||||||
229<\/td>\n | Annex I (informative) Establishment of allowable limits for EG <\/td>\n<\/tr>\n | ||||||
233<\/td>\n | Annex J (informative) Preparation of EO and ECH standards <\/td>\n<\/tr>\n | ||||||
237<\/td>\n | Annex K (informative) Ethylene oxide residue measuring methods <\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":" Tracked Changes. Biological evaluation of medical devices – Ethylene oxide sterilization residuals<\/b><\/p>\n |